Integra LifeSciences Holdings Corporation
IART
$22.24
-$1.71-7.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 273.57M | 277.60M | 296.93M | 677.29M | 309.10M |
| Total Receivables | 272.37M | 256.13M | 277.78M | 248.57M | 259.33M |
| Inventory | 429.09M | 436.93M | 421.78M | 403.42M | 389.61M |
| Prepaid Expenses | 77.00M | 86.33M | 93.64M | 72.67M | 67.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.65M | 42.54M | 22.17M | 13.70M | 32.64M |
| Total Current Assets | 1.08B | 1.10B | 1.11B | 1.42B | 1.06B |
|
|
|||||
| Total Current Assets | 1.08B | 1.10B | 1.11B | 1.42B | 1.06B |
| Net Property, Plant & Equipment | 549.77M | 537.25M | 521.04M | 497.19M | 496.38M |
| Long-term Investments | 1.10B | 1.12B | 1.10B | 1.04B | 1.06B |
| Goodwill | 1.10B | 1.12B | 1.10B | 1.04B | 1.06B |
| Total Other Intangibles | 1.21B | 1.21B | 1.22B | 1.02B | 1.07B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 63.14M | 76.49M | 73.14M | 61.54M | 73.56M |
| Total Assets | 4.04B | 4.07B | 4.07B | 4.08B | 3.78B |
|
|
|||||
| Total Accounts Payable | 82.50M | 77.67M | 107.49M | 94.40M | 92.33M |
| Total Accrued Expenses | 169.74M | 178.06M | 170.95M | 123.87M | 144.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 622.30M | 616.81M | 39.44M | 36.22M | 30.39M |
| Total Finance Division Other Current Liabilities | 47.59M | 40.03M | 10.44M | 47.91M | 39.55M |
| Total Other Current Liabilities | 47.59M | 40.03M | 10.44M | 47.91M | 39.55M |
| Total Current Liabilities | 922.13M | 912.56M | 328.32M | 302.39M | 306.98M |
|
|
|||||
| Total Current Liabilities | 922.13M | 912.56M | 328.32M | 302.39M | 306.98M |
| Long-Term Debt | 1.20B | 1.21B | 1.80B | 1.84B | 1.49B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 166.93M | 167.81M | 169.56M | 170.08M | 166.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 205.93M | 257.07M | 240.02M | 169.59M | 234.01M |
| Total Liabilities | 2.49B | 2.54B | 2.54B | 2.48B | 2.19B |
|
|
|||||
| Common Stock & APIC | 1.32B | 1.32B | 1.30B | 1.31B | 1.30B |
| Retained Earnings | 939.92M | 920.48M | 931.18M | 943.58M | 946.86M |
| Treasury Stock & Other | -718.98M | -716.66M | -699.48M | -657.07M | -662.37M |
| Total Common Equity | 1.55B | 1.52B | 1.53B | 1.60B | 1.59B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.55B | 1.52B | 1.53B | 1.60B | 1.59B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.55B | 1.52B | 1.53B | 1.60B | 1.59B |
|
|
|||||
